Stress Signals Activate Natural Killer Cells by Long, Eric O. & Rajagopalan, Sumati
 
The Journal of Experimental Medicine • Volume 196, Number 11, December 2, 2002 1399–1402
http://www.jem.org/cgi/doi/10.1084/jem.20021747
 
Commentary
 
1399
 
Stress Signals Activate Natural Killer Cells
 
Eric O. Long and Sumati Rajagopalan
 
Laboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 
Rockville, MD 20852
 
The mechanisms that regulate NK cell function as a first
line of defense against infection and transformation have
exceeded our expectations in terms of their sophistication
and complexity. Quiescent, circulating NK cells can be ac-
tivated by either soluble mediators, such as interferons and
cytokines, or by direct cell–cell contact. Activation occurs
during contact not only when NK cells sense the loss of
MHC class I expression on the surface of other cells but
also with cells that have undergone other alterations in-
duced by infection or cellular stress. Notably, expression of
ligands for receptor NKG2D induced by stress or transfor-
mation results in activation signals that can overcome the
inhibition mediated by MHC class I–specific receptors (1–
4). Yet another mode of NK cell activation upon cellular
stress is described in this issue by Michaëlsson et al. (5). Re-
placement of a peptide on an MHC class I molecule by a
peptide released from a heat shock protein prevents recog-
nition by an NK cell inhibitory receptor. Therefore, pro-
cessing of a heat shock protein, which can occur during the
cellular stress that accompanies infection or inflammation,
into a peptide that modifies an MHC class I molecule rep-
resents another mechanism for the immunosurveillance of
stressed cells by NK cells.
Both the innate and adaptive arms of the immune system
are galvanized upon infection or transformation of healthy
cells. Antigen-specific receptors of the adaptive immune
system are selected to make the important distinction be-
tween normal structures and those that are either foreign or
aberrant. In contrast, the innate immune system uses recep-
tors that recognize structurally conserved molecular pat-
terns on microorganisms, such as polysaccharides and CpG
nucleotide sequences. NK cells are a subpopulation of lym-
phocytes that bridge these two arms of the immune re-
sponse. While they do not use V(D)J recombination to
generate antigen-specific receptors, they nevertheless use a
complex arsenal of receptors that either activate or inhibit
their effector functions (cytotoxicity and/or cytokine re-
lease). There are multiple NK cell activation receptors on a
given NK cell, which recognize ligands expressed on other
cells, and an array of inhibitory receptors that monitor the
integrity of MHC class I expression on other cells.
 
Missing Self.
 
The ‘missing self’ hypothesis was the first
breakthrough in understanding specific recognition of tar-
get cells by NK cells, when it was appreciated that loss of
MHC class I expression leads to sensitivity to lysis by NK
cells (6). The hypothesis was validated by the discovery of
three different families of inhibitory receptors specific for
MHC class I on human and mouse NK cells that regulate
self-tolerance of NK cells. Human NK cells express the
family of killer cell Ig-like receptors (KIRs), and mouse
NK cells express the Ly-49 family of lectin-like receptors,
that bind classical class I molecules (7, 8). In addition, a het-
erodimer of the lectin-like CD94 and NKG2A in humans
and mice binds the nonclassical class I molecule HLA-E
and Qa1, respectively (8). The clonal distribution of these
inhibitory receptors is such that some human NK cells are
inhibited by recognition of HLA-B or HLA-C by a KIR,
while others are inhibited by recognition of HLA-E by
CD94/NKG2A (9; Fig. 1). The down-regulation of MHC
 
molecules frequently observed in tumors and in virus-
infected cells can lead to sensitivity to NK cells. The loss of
inhibitory signals due to a reduction in HLA class I on tar-
get cells usually results in NK cell activation because the
ligands of the many activation receptors (e.g., NKp46,
NKp44, NKp30, 2B4, etc.) are widely expressed, particu-
larly on hematopoietic cells (10). However, NK cells can
also be activated by cells that still express MHC class I.
 
Stress-inducible Ligands.
 
It has become evident recently
that factors other than MHC class I expression are deter-
minants of sensitivity to NK cells. Binding of activation re-
ceptor NKG2D to inducible ligands on target cells leads to
elimination by NK cells, despite normal expression of
MHC class I (1–4). NKG2D binds with high affinity to a
number of different ligands, which are distantly related to
MHC class I, such as MICA/MICB and ULBP proteins in
humans, and Rae-1 and H60 proteins in mice (11). These
proteins are generally not expressed on normal cells but
can be induced by stress and up-regulated on tumors and
virally infected cells (12–14). Engagement of NKG2D by
its ligands on target cells either bypasses or overcomes the
inhibition provided by MHC class I–specific receptors
(Fig. 1). NKG2D is also expressed by activated CD8
 
 
 
 T
cells and is present on some 
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cells. NKG2D provides potent costimulation to CD28
 
 
 
virus-specific CD8 T cells (12). In addition, NKG2D ex-
pression is inducible in macrophages by treatment with li-
popolysaccharides, interferon-
 
 
 
/
 
 
 
, and interferon-
 
 
 
 (15).
The ubiquitous expression of NKG2D on NK cells and
the inducible expression of its ligands on other cells pro-
vides an efficient mechanism for the rapid activation of
NK cells which is not tied to down-regulation of MHC
class I.
 
Stress-induced HLA-E Modification.
 
Another strategy for
detection of stressed cells has now been revealed by the
work of Michaëlsson et al. (5). HLA-E is the relatively
nonpolymorphic ligand of CD94/NKG2A and CD94/
NKG2C. It has a very selective preference for nonameric
 
peptides, derived from the signal sequence of other class I
molecules, that contain conserved anchor residues at posi-
tion 2 and 9 (16). However, the amino acid sequence of
the peptide in HLA-E is known to affect binding by
CD94/NKG2A (17, 18). Similarly, the mouse functional
homologue of HLA-E, Qa1, binds mouse CD94/NKG2A
only if certain amino acids are present at position 5 (19). In
fact, Kraft et al. have suggested that competitive peptide re-
placement in Qa1 may provide a mechanism for activation
of NK cells (19). In the new study reported in this issue (5),
a peptide from the signal sequence of stress protein hsp60 is
shown to load onto HLA-E and to compete effectively
with an MHC class I–derived peptide. Furthermore, HLA-E
loaded with the hsp60-derived peptide does not bind
Figure 1. Outcomes of sur-
veillance by NK cells. NK cells
survey cells for changes in self,
represented here by MHC class I
and MHC class I–related mole-
cules (e.g., ULBP, MICA). (1)
Depicts an NK cell that is inhib-
ited by the HLA-E-specific re-
ceptor CD94/NKG2A, and (2)
depicts one that is inhibited by
an HLA-C–specific KIR. The
KIR family also includes inhibi-
tory receptors with three Ig do-
mains that bind to HLA-A and
HLA-B. A representative activa-
tion receptor (AR) of the natural
cytotoxicity receptor family is
shown in association with an im-
munoreceptor tyrosine-based ac-
tivation motif (ITAM)-contain-
ing subunit, such as DAP12. NK
cells express multiple activation
receptors on their cell surface.
NKG2D is a lectin-like receptor
that is associated with the sub-
unit DAP10. (A) “Missing self”:
a global down-regulation of the
expression of MHC class I mole-
cules, as seen in certain tumors
or during viral infections, results
in the loss of surface HLA-E.
The lack of engagement of the
inhibitory CD94/NKG2A leads
to activation of NK cells (A1).
The loss of a single class I allo-
type, such as HLA-C, may acti-
vate NK cells that express an
HLA-C-specific inhibitory KIR
(A2). (B) “Induced self”: expres-
sion of ligands of NKG2D is in-
duced on target cells due to cel-
lular stress, transformation, or
viral infections and results in an
activation of NK cells despite the
presence of inhibitory receptors
(Superactivation). It is not
known if NKG2D engagement bypasses inhibition or if it overrides inhibition by enhancing activation signals from other receptors. ULBP is a family of
molecules with  1- 2 domains. NKG2D binds also to MICA and MICB, which have  1- 2- 3 domains. ULBP and MICA/B proteins are not associ-
ated with  2-microglobulin and do not bind peptides. (C) “Modified self”: stress-induced molecule hsp60 provides a signal sequence-derived peptide
that binds to HLA-E and prevents recognition by inhibitory CD94/NKG2A. This results in activation of NK cells expressing CD94NKG2A (C1) but
not of NK cells expressing inhibitory KIR (C2). 
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CD94/NKG2A or CD94/NKG2C. The side chain at po-
sition 5 of that peptide contributes to the lack of binding.
The authors further show that coexpression of hsp60 with
HLA-E in transfected cells up-regulates surface expression
of HLA-E. Enhanced surface expression of HLA-E was
also observed in stressed cells and did not result in increased
protection from NK cells. Although not shown experi-
mentally, it seems feasible that peptides derived from stress-
induced hsp60 could achieve competitive peptide replace-
ment in HLA-E in a physiological situation because peptides
derived from signal sequences of MHC class I are appar-
ently in limited supply. Indeed, expression of several HLA
class I alleles is necessary to obtain maximal protection from
NK cells that are inhibited through HLA-E recognition by
CD94/NKG2A (9).
A competing strategy to avoid recognition by NK cells is
used by CMV. A peptide derived from the signal sequence
of the CMV glycoprotein UL40 binds to HLA-E and up-
regulates its expression (20). The UL40-derived peptide is
loaded onto HLA-E independently of the peptide trans-
porter TAP and is recognized by CD94/NKG2A, which
makes escape possible even in cells where TAP has been
disabled. The specific nature of the peptide bound to HLA-E
can also modulate NK cell responses in other ways. Some
NK cells express the activating receptor CD94/NKG2C.
Surprisingly, HLA-E loaded with a peptide derived from
the signal sequence of the nonclassical class I molecule
HLA-G, whose expression is limited to a few cell types, fa-
vored recognition by NKG2C over that by the inhibitory
NKG2A (21). Even though binding of tetrameric HLA-E
loaded with the hsp60 signal peptide to cells expressing
CD94/NKG2C was undetectable, it would be interesting
to test if there is functional recognition of stress-modified
HLA-E by this activating receptor, as it would enhance
NK cell responses even further. In addition to its role in in-
hibition of NK cells, HLA-E loaded with self and viral
peptides can activate a subset of CD8
 
 
 
 T cells (22). It re-
mains to be seen whether the hsp60-derived peptide will
suppress or activate T cell responses, by either competing
with peptides recognized by those T cells or by inducing
hsp60-specific T cell responses.
 
Peptide Matters.
 
The influence of MHC class I–bound
peptide on recognition by inhibitory receptors had previ-
ously been reported for the KIR3DL and KIR2DL recep-
tors specific for HLA-B and HLA-C, respectively (23, 24).
Although many different peptides are compatible with rec-
ognition by KIR, certain side chains at position 7 and 8 of
the nonamer peptide interfere with KIR binding. Crystal
structures of two KIR2DL:HLA-C complexes confirmed
why these receptors bind only when certain peptide side
chains are present. Direct contacts are made by KIR with
the peptide backbone, and certain peptide side chains can-
not be accommodated in the tight space (25, 26).
The reason for the peptide selectivity in the recognition
of HLA-B and HLA-C by inhibitory KIR has remained
elusive. It is clear that such selectivity is not the basis for
self/nonself discrimination by NK cells since there is no
correlation between the protective effect of a peptide and
its origin. In other words, self-peptides and viral peptides
that have been eluted from HLA class I come in both fla-
vors, those that are compatible with KIR binding and those
that are not. Regardless, a strategy similar to that used by
HLA-E through a stress-induced peptide is not feasible in
the case of KIR recognition because of the very high allelic
polymorphism of its HLA-B and HLA-C ligands. Each in-
hibitory KIR recognizes a large group of HLA ‘allotypes’
that share specific structural determinants but otherwise
bind completely different sets of peptides. Therefore, it is
not possible for a nonpolymorphic self protein to carry all
possible combinations of anchor residues for binding to
multiple HLA allotypes and to include an amino acid side
chain at the right position in all cases to block KIR binding.
Unlike inhibitory KIR which bind MHC class I on top
of the peptide binding groove, the lectin-like Ly-49A in-
hibitory receptor in mice has a completely different bind-
ing site, far removed from the peptide binding site (27, 28).
Thus, there is no apparent peptide specificity for MHC
class I recognition by Ly49A, and the contribution of pep-
tides bound to H-2D
 
d
 
 is to ensure proper folding and cell
surface expression (29).
 
Conclusions.
 
In addition to revealing a novel strategy
used by stressed cells to initiate NK cell activation, the new
findings of Michaëlsson et al. also illustrate how useful the
dual system of inhibition by KIR and CD94/NKG2A can
be. These two receptor systems are not simply redundant.
For example, loss of a single HLA-B or HLA-C allele, as
occurs frequently in tumor cells, could not be detectable by
NK cells expressing CD94/NKG2A, whereas NK cells in-
hibited by a KIR specific for the product of the lost allele
will get activated (Fig. 1). Conversely, stress-induced mod-
ification of HLA-E would not prevent inhibition of NK
cells expressing inhibitory KIR but would activate CD94/
NKG2A-expressing NK cells due to loss of inhibition (Fig.
1). It will be important to test the role of HLA-E in alert-
ing NK cells to cellular stress in physiological settings such
as infections or inflammation. Furthermore, given the
widespread expression of CD94/NKG2A on cytotoxic T
cells, it remains to be seen whether this stress-induced im-
munosurveillance mechanism can also switch the inhibition
of T cell effector functions to activation, thereby influenc-
ing the adaptive arm of the immune response as well.
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